Lixte Biotechnology Inc.

NASDAQ: LIXT · Real-Time Price · USD
3.75
-0.15 (-3.85%)
At close: Aug 15, 2025, 2:31 PM

Lixte Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-3.57M -5.09M -6.31M -6.72M
Interest Income
7.05K 1.25K 11.2K 626.00
Pretax Income
-3.59M -5.09M -6.31M -6.73M
Net Income
-3.59M -5.09M -6.31M -6.73M
Selling & General & Admin
2.85M 4.19M 4.96M 4.98M
Research & Development
726.23K 898.1K 1.35M 1.74M
Other Expenses
-232 -100 n/a n/a
Operating Expenses
3.57M 5.09M 6.31M 6.72M
Interest Expense
n/a n/a 8.88K 7.41K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
3.57M 5.09M 6.31M 6.72M
Income Tax Expense
n/a n/a -7.82K 6.79K
Shares Outstanding (Basic)
2.25M 1.91M 1.58M 1.35M
Shares Outstanding (Diluted)
2.25M 1.92M 1.58M 1.35M
EPS (Basic)
-1.59 -2.66 -4 -5
EPS (Diluted)
-1.59 -2.66 -4 -5
EBITDA
-3.57M 3.21K -1.05K -7.95K
EBIT
-3.59M -5.09M -6.31M -6.73M
Depreciation & Amortization
30K 5.09M 6.31M 6.72M